Hypothalamic blood flow (HBF) was measured in the conscious rabbit using a 133 xenon clearance technique. The effects of intrahypothalamic norepinephrine (NE) and 5-hydroxytryptamine (5-HT) were determined by adding these compounds to the 133 xenon-in-saline injectate, in varying concentrations. NE produced dose-dependent changes in flow; 1 /xg/ injection caused a mean increase in HBF of 55%, while doses of 10, 20, 40 and 200 fig/ injection reduced HBF by mean values of 26%, 17%, 20% and 29% respectively. The constrictor effect of NE 40 fig/injection was prevented by the addition of phenoxybenzamine 50 //.g/injection. Intrahypothalamic injections of 5-HT (20, 40 and 80 ^.g/injection) caused increases in mean HBF of 24%, 54% and 69% respectively. Injections of NE into the lateral cerebral ventricles caused an increase in HBF; 5-HT produced a variable response, but mean values for HBF tended to be lower after the injection. There were no changes in mean arterial blood pressure or arterial Pco 2 . It is concluded that NE and 5-HT have an action on hypothalamic resistance vessels when applied from the adventitial side, and that, in the case of NE, the response is dose dependent, and the vasoconstrictor effects may be mediated by alpha receptors in hypothalamic vessels.
vasoconstrictor (5, 6) and vasodilator (7) . There are difficulties in the interpretation of these results because the intravenous administration of those vasoactive drugs which alter mean arterial blood pressure might affect cerebral vessels via autoregulation of cerebrovascular tone in response to the blood pressure change rather than by any direct action on the cerebral vasculature. In addition, since in many of these studies only total cerebral blood flow was studied, any local flow changes in the brain might have been missed.
The role of a neural mechanism in the control of cerebral blood flow is a question of considerable controversy (8, 9) . There is, however, good evidence that in various species, including the rabbit, there is a rich adrenergic innervation of the cerebrovascular system (10, 11) situated in nerve plexuses on the adventitial side of the media. This subadventitial location of the adrenergic plexus, as well as the responsiveness of isolated blood vessels to externally applied NE and 5-HT (12-14), would suggest that parenchymal vessels in the brain might respond to these drugs applied externally.
For these reasons we have examined the effects of local application of these amines on local cerebral blood flow in a conscious animal. The method used in this study for the measurement of local blood flow is based on the rate of clearance of locally injected ]33 xenon ( 133 Xe); this technique allows for the addition of NE or 5-HT to the injectate, so that intrahypothalamic injections of these agents may be made into the same region from which local blood flow is recorded.
The anterior hypothalamus was studied because NE and 5-HT are normally present in relatively high concentrations in this area (15, 16) and because it is a relatively large area of subcortical gray matter in the rabbit, with monoexponential 133 Xe clearances suggesting homogeneity of blood flow. There is evidence, also, that local injections of NE and 5-HT into the hypothalamus cause changes in body temperature, and one way in which they could do so is by altering hypothalamic blood flow.
This paper therefore records the results of experiments designed to determine the effect of NE and 5-HT administered by intraventricular or intrahypothalamic injection on local cerebral blood flow in the hypothalamus of the conscious rabbit.
Methods

GENERAL
At least two weeks before the experiment, a headplate was fixed to the skull, under pentobarbital anesthesia, 30 mg/kg. This headplate, similar to that described by Cooper et al. (17) , was placed so that the stereotaxic coordinates developed by Monnier and Gangloff (18) could be used to achieve access to the hypothalamus with thermistors or injection cannulas. Subsequently, the animal was allowed at least two 3hour sessions in the stocks for the purpose of accustoming it to the mild restraint required.
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Experiments were performed in a room with the ambient temperature kept between 21 and 24° C and a variability during any single experiment of less than 1°C. The rabbits were restrained in conventional stocks, and their heads stabilized by a rubber-lined constraining apparatus. The procedure did not appear to cause any distress to the animals; at least 1 hour was allowed to elapse before any blood flow measurements were made.
Rectal temperatures were recorded with a glass bead thermistor mounted in a polyethylene catheter inserted at least 5 cm into the rectum. Hypothalamic temperature was measured with a small glass bead thermistor mounted in a nonbeveled needle (o.d. 0.5 mm) and placed with its tip in the anterior hypothalamus on the control side. The rectal and hypothalamic thermistors were connected to bridge circuits, the outputs from which were recorded on an ultraviolet (UV) recorder (SE 2005) and a digital data logging system (Solartron LY.1470).
In most experiments, arterial pressure was monitored via a 00 nylon catheter in the central ear artery, connected to an Ether blood pressure transducer, and in some, arterial Pco 2 was measured at intervals using a Radiometer electrode.
Fine injection cannulas, 0.4 mm o.d., were placed with their tips in the anterior hypothalamus in equivalent positions on either side of the midline; each cannula was connected via a 2m length of 00 nylon tubing to a Hamilton 250-/iliter microsyringe and the whole system was filled with 138 Xe-saline solution (5 me/ml) (Radiochemical Centre, Amersham, Bucks, England). The tips of the injection cannulas were 1.5 mm from the midline, and 3.0 mm from each other.
Microinjections of 5 to 10 fig 133 Xe dissolved in sterile pyrogen-free normal saline (5 me/ml) were made into each side of the hypothalamus alternately. The duration of each injection was about 2 to 3 seconds. In most cases, at least 10 minutes was allowed between injections. The clearance rates of the 133 Xe were monitored by an external collimated scintillation counter, amplifier, pulse height analyzer and ratemeter system, and recorded on the UV recorder and the digital data logger. The time constant of the ratemeter was either 3 seconds for the first 30 seconds of the clearance curve and 10 seconds thereafter, or was 10 seconds throughout. Since the half-decay time for 133 Xe clearance from the site of injection was rarely less than 1 minute, and was usually about 100 seconds, T s O . l K, where T = the time constant value RC of the ratemeter assembly, and K is the time constant value for the exponential decay of activity during clearance (the input function). When this relationship holds, the observed rate of clearance, where T = 10 seconds, is very close to the input function rate of clearance. Mean background activity, which was high (100 to 300 counts/sec) because of the two 133 Xe-filled cannulas, was subtracted from the exponential clearance curve which followed each injection, and the half-decay time (f*) was computed from the first 1 to 2 minutes of the semilogarithmic plot of the clearance curve. Figure 1 shows a typical clearance curve. The clearance of injected 133 Xe was monoexponential in all experiments, suggesting homogeneity of flow within the area of diffusion of the tracer.
Blood flow (ml/100 g tissue/min) was calculated as
where Xxe is the brain-blood partition coefficient for 1S8 Xe in the rabbit hypothalamus, and t 1 is the half-decay time (min) of the clearance curve.
PRELIMINARY EXPERIMENTS Determination of Xsc
In a preliminary series of experiments we measured Xxo in the rabbit hypothalamus. Xx* is difficult to measure directly because 133 Xe comes out of solution very rapidly when exposed to air. A double isotope method for the measurement of Xx. was devised, the principle of which is as follows. 133 Xe and 125 I are both y-emitters. Approximately equal doses of 133 Xe and 125 Iantipyrine ( 125 IAP) dissolved in saline were mixed and injected into the tissue studied. The simultaneous clearance of these two tracers was then measured with an external scintillation counter. In these circumstances, since the two isotopes are being cleared by the same blood flow, the ratio of their half-decay times will be related to the ratio of their respective X values, thus
The second series of experiments was designed to determine XIAP. The nonvolatile 125 I-antipyrine was dissolved in saline and injected intravenously into the animal. After equilibration was reached the animal was killed and 125 I-antipyrine activity in the tissue and in blood was measured. Tissue and blood activities were corrected for the presence of free iodide, and the ratio of the 125 Iantipyrine activity in unit mass of tissue and blood (XIAP) was calculated.
With t' Ax«, t'-4i*p, and XIAP known, Xx* could then be calculated. Preliminary experiments, based on this principle, details of which have been described elsewhere (19) , produced a value for XXO/XIAP of 0.73 ± 0 . 0 6 (SE) and X.AP= 1.02 ±0.01 (SE). XK* is therefore 0.74.
Maintenance of Autorcgulotion
Cerebrovascular autoregulation is easily abolished, for example, by trauma, vascular perfusion procedures, periods of circulatory arrest, arterial and local tissue hypoxia, hypercapnia, and deep anesthesia. Preliminary experiments were carried out to determine whether the trauma induced by the presence of the cannula and the microinjec- 1.09 BF = hypothalamic blood flow in ml/100 g/min; F/MF = ratio of BF to the mean BF at a mean arterial blood pressure of 81-100 mm Hg, which was taken as the "normal" range, and the mean hypothalamic blood flow for each rabbit at that pressure called 1. All other flows in that experiment at other blood pressure levels were expressed as a ratio of this value. This allowed a comparison between different animals, which vary considerably in their "normotensive" hypothalamic blood flow values. P = significance of difference from control mean F/FM ratio of 1.
tion of a solution of 133 Xe in saline into the hypothalamus would abolish autoregulation at that site. Forty-eight measurements of hypothalamic blood flow (HBF) were made in seven rabbits anesthetized with pentobarbital 30 mg/kg, and maintained on intermittent positive pressure respiration via a tracheostomy to maintain the arterial Pco 2 constant during the experiment.
Stepwise increments of mean arterial blood pressure could be produced by intravenous infusion of angiotensin II amide (Hypertensin, Ciba); blood pressure could be reduced by withdrawal of 10 to 20 ml of blood via an arterial catheter. At each blood pressure level, the HBF was measured. Within the range of mean arterial pressure of 41 to 140 mm Hg, there was no significant change in mean HBF (Table 1 ).
INTRAHYPOTHALAMIC INJECTIONS
The first experiments (two rabbits) were designed to test the assumption that there is no systematic difference in hypothalamic blood flow on either side of the midline. When this was demonstrated (see Results), the next series of experiments was planned as follows. In each experiment one side of the hypothalamus was designated the control side and received injections of 133 Xe in saline only. The injection system on the opposite side was primed with the same solution, to which the drug under examination was added to make up the appropriate final concentration In all experiments, clearances of 133 Xe were measured alternately on the control side and the test side, and the flow on the test side was expressed as a percent of the mean of the control flows immediately preceding and following it. Three, four, or five injections were made into each side of the midline during the course of any one experiment. Since in most cases at least 10 minutes was allowed to elapse between any two successive injections, the interval between successive injections on the same side was usually about 20 minutes.
The recording thermistor was positioned on the control side; its tip was 3 mm posterior to the tip of the control injection cannula.
INTRAVENTRICULAR INJECTIONS
In this series, 22 experiments were performed, 13 involving norepinephrine and 9 5-HT. The rabbits were prepared in the manner described in the previous section. In these experiments, however, the hypothalamic blood flow was measured on one side only, and hypothalamic temperature measured on the same side. Another injection cannula was inserted with its tip in the opposite lateral ventricle, for the injection of NE, 5-HT, or a saline control. Rectal and hypothalamic temperature and hypothalamic blood flow were recorded as before.
The preliminary intraventricular injection of 0.2 ml of normal saline alone resulted in a variable, small (<0.1°C), and transient ( < 1 minute) fall of hypothalamic temperature and had no effect on hypothalamic blood flow, rectal temperature, or arterial blood pressure.
In each experiment at least two basal measurements of hypyothalamic blood flow were made, followed by injection into the lateral ventricle of As a control series for the experiments involving the intraventricular injections of NE and 5-HT described above, eight experiments were performed (49 blood flow readings) in which the conditions of these NE and 5-HT experiments were reproduced exactly, except that a saline (0.2 ml) control was used instead of the NE or 5-HT solution. This provided an indication of changes in hypothalamic blood flow with time.
Results
INTRAHYPOTHALAMIC INJECTIONS
Equality of Flow on Both Sides of the
Midline.- Figure 2 shows the results of one experiment. There was no systematic difference in blood flow on the two sides in this experiment. In these experiments, microinjec-tions of 133 Xe were given on alternate sides, and blood flow on the right side calculated as a percent of the mean of the preceding and succeeding flows on the left side.
In eight comparisons of this kind, blood flow on the right averaged 101 ±1.4% (SE) of that on the left. This value is not significantly different from 100% (f = 0.71, P>0.2), so that the use of flows on one side as a control for flow changes on the opposite (test) side appeared to be valid.
FIGURE 3
A typical experiment showing the effect on hypothalamic blood flow (FJ of NE (1 ng/'injection). Each solid circle represents one injection of lss Xe in saline into the control side and each open circle one injection of the NE-" s Xe-saline solution on the test side.
The lowest trace is hypothalamic temperature in °C. Intrahypotlialamic Norepinephrine.- Figure  3 shows, in one experiment, that 1 /xg NE/injection increases hypothalamic blood flow; this is true of all the results using norepinephrine in this dose, the mean being 155.0 ± 12.7% (SE), of flow on the control side ( P < 0.0025, N = 11).
The results for 2 /xg NE/injection showed a large scatter (Fig. 4) , with a very slight but not significant decrease in blood flow, the mean being 96.4 ±23.9% (SE) of flow on the control side (P>0.05, N = 18). The three highest points were values from one experiment; in the other three, most or all of the compared with basal flow. Figure 9 shows the results for NE given in this way. It is clear that the results, although quite variable, show a trend to an increase in blood flow, which is significant at 20 to 40 minutes (123.6 ± 8.0%) (SE), (P<0.05, N = 1 2 ) . The mean of the values for over 40 minutes is 109.8%, which would suggest that the blood flow, although still raised (P<0.05), was returning to control values. Similar levels of significance were obtained when these results were compared with the mean flows seen after saline injection in the control series shown in Figure  8 . No change in arterial blood pressure was produced by NE in any of these experiments. In one, there was no change in hypothalamic temperature; in the others, it rose 0.1 to 0.84°C. Intraventricular 5-HT.-The results of these experiments are shown in Figure 9 ; mean values for each 20-minute period were compared to 100% and also to mean values for the same expression derived from the control experiments (Fig. 8) . The scatter of blood flow values was large. There was a fall in mean flow to 76.1 and 77.6% of the mean control value in the periods 0 to 20 and 20 to 40 minutes, respectively, but in neither period was the fall statistically significant.
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In this series of experiments the fall in hypothalamic and rectal temperatures was of the same order (0.05° to 0.2°C) but lasted longer (up to 30 minutes) than that produced by 5-HT injected directly into the hypothalamus. No 5-HT-induced change in arterial blood pressure was seen nor was there any significant change in arterial Pco 2 .
Discussion
METHOD
The clearance of the injected 133 Xe appeared to be monoexponential, at least down to 5 to 10% of the count rate above background. At this level, when the activity approached the high background level, the scatter of points on a semilogarithmic plot of the clearance was so great that it was not possible to continue the regression line down to background. It is therefore impossible to exclude with absolute certainty a second component to the curve; if such a component exists, it must be very small.
The finding that the 133 Xe clearance curves (both in the control studies and after the local injection of NE and 5-HT) were monoexponential has several implications. The first is that flow was homogeneous within the area of diffusion of the tracer; the second is that if there was leakage of xenon along the cannula tract (even though the cannula was left in situ throughout the experiment) the tracer remained within a homogeneously perfused region. If, after the NE or 5-HT injections, the flow was continuously changing during the period of measurement, the clearance of the indicator might be expected to deviate from a monoexponential function. Another conclusion, therefore, from the monoexponential clearances of the tracer after the drug injections, is that new steady-state conditions are achieved rapidly compared to the rate of clearance of the indicator, and are maintained for at least as long as the linear portion of the clearance curve.
The maintenance of autoregulation, which in other circumstances is readily abolished by trauma and ischemia, is another factor in support of the validity of this technique. It is not suggested that local blood flow is not affected by the presence of the injection cannula, but the use of an identical injection system on the control side permits at least semiquantitative observations on the effects of vasoactive drugs on local flow.
NOREPINEPHRINE
Haggendal (1) has demonstrated a vasoconstricting effect on cerebral vessels, of intravenously infused norepinephrine in the dog. In normotensive man, pressor doses of lnorepinephrine, whether administered intramuscularly (20) or by continuous intravenous infusion (2-4) produced either no change or a small fall in cerebral blood flow. The resulting increase in cerebrovascular resistance was interpreted at that time as indicating a cerebral vasoconstrictor action of NE (20) . However, since the existence of cerebrovascular autoregulation is now recognized, it is clear that an increased resistance can also occur in response to an elevated systemic arterial blood pressure. Thus the increase in cerebrovascular resistance following NE injection or intravenous infusion does not necessarily imply that the drug has a direct effect on the cerebral vasculature.
Green and Denison (21) , using an electromagnetic flowmeter to measure blood flow continuously in an isolated canine cerebral circulation preparation, showed that intracarotid injections of NE had no effect on the cerebral vascular bed. Greenfield and Tindall (22) investigated this problem in man. Arterial blood pressure and flows in the internal and external carotid artery were measured continuously with electromagnetic flowmeters during surgical exposure of these vessels. Intravenous administration of NE was accompanied by an increase in cerebrovascular resistance, injections of NE into the external carotid artery were accompanied by an immediate decrease in blood flow through that artery due to a direct action on the vascular bed supplied by the external carotid, but NE injections into the internal carotid artery had no immediate effect. They concluded that NE had no direct action on the cerebral vascular bed but that the increased cerebral vascular resistance following intravenous administration of NE was due to autoregulation.
The results of the present study suggest that there is a dose-dependent opposite effect of NE on hypothalamic blood flow in the conscious rabbit when the amine is injected directly into the hypothalamus. Doses of 1 jotg/injection increase local flow, and doses of 10 ft,g or more/injection reduce the hypothalamic blood flow, compared to the opposite (control) side. These alterations in flow were not due to changes of arterial pressure or Pco 2 .
The vasoconstrictor effect of 40 /ug/injection of NE into the hypothalamus was prevented by the addition of 50 /xg of the alpha-receptorblocking drug phenoxybenzamine. This would suggest that NE activates alpha receptors in hypothalamic vessels. It remains an open question whether the effects of the relatively large doses used in this study provide any indication of a physiological role of the amine. Also, it is obviously impossible to predict the response of vessels in other areas of the brain; it is quite possible that there is a regional variability in the responsiveness of cerebral vessels to exogenous NE.
On intraventricular injection of NE, there was a variable rise of hypothalamic blood Injection of NE into the cerebral ventricle or hypothalamus of the rabbit causes an increase in body temperature (17) . It is possible that hypothalamic NE and 5-HT are concerned, as neurotransmitters, in the regulation of body temperature, but it has been suggested that the injection of these agents causes local alterations in hypothalamic temperature by influencing blood flow. This seems extremely unlikely, because intrahypothalamic NE causes a rise of body temperature at all doses, and the effects on flow are different at high and low doses.
5-H YOROXYTRYPTAMIN E
The reported effect of 5-HT on systemic blood pressure and organ blood flow varies greatly according to the animal species, the anesthetic used, the route of administration, and the dose. For example, 5-HT causes vasoconstriction of most mammalian vessels-human forearm and umbilical vessels, rabbit ear artery and pulmonary vessels-and this is abolished by lysergic acid derivatives (23) (24) (25) (26) .
The present study has shown that 5-HT, when injected into the rabbit hypothalamus in doses of 20, 40 and 80 fig, causes a local vasodilatation. This is unlikely to be due to a nonspecific effect of body temperature change on hypothalamic blood flow, since an increase in flow may be produced by an increase in skin and core temperature by radiant heating (unpublished data). In the case of 5-HT, Circulation Research, Vol. XXVlll, April 1971 however, the increment of hypothalamic flow was associated with a small transient and variable fall in core temperature and cannot therefore be caused by it. On the other hand, one intraventricular injection of 200 fig of 5-HT is followed by a sustained fall in hypothalamic flow. The mechanism of this effect can only be speculated upon. It is reasonable to suppose that this action of 5-HT is a local vasomotor effect in the brain and not the result of any change in systemic arterial pressure or Pco 2 since no such change was observed in the rabbits in which these variables were measured. Also there is no reason to believe that autoregulatory capacity was impaired in the 5-HT experiments although this was not tested directly.
A dose-dependent, opposite effect has been described with reference to the intravenous 5-HT action on arterial blood pressure (27) and appears to apply to NE in the rabbit hypothalamus, so it is not inconceivable that a similar relationship exists for 5-HT. This is unlikely but cannot be entirely excluded on the available evidence. Unlike the NE injections, in which the smallest dose had an effect opposite to that of the larger doses, local injections of 5-HT showed no dose-dependent opposite effect in these experiments. It may be that doses of 5-HT even smaller than 
